Table 2. Characteristics of immune induction depending on the routes of mucosal immunization.
| Route of immunization | Effective compartment | Form | Characteristics (advantage/disadvantage) | Examples | Reference |
|---|---|---|---|---|---|
| Oral | Gastrointestinal tract, salivary gland, mammary gland | Liquid, pills | Enhances immune response both in systemic and mucosal areas; safe; easy to vaccinate; easy to scale up/induction of tolerance, the harsh environment of the gastrointestinal tract | Rotavirus, Poliovirus, Salmonella typhi, Vibrio cholera, Cholera toxin | 6 |
| Intranasal | Upper respiratory tract, genital tract | Sprays, drop | Enhances immune response both in systemic and mucosal areas; easy to vaccinate/side effects such as Bell's palsy, damage to nasal epithelium | Influenza type A, H1N1 influenza | 29 |
| Pulmonary | Respiratory tract | Aerosol, powders | Enhances immune response both in systemic and mucosal areas; easy to vaccinate, simplified logistics/requirement of device, difficulty in vaccination | Edmonston-Zagreb | 30 |
| Sublingual | Respiratory and gastrointestinal tracts | Liquid, pills | Quick diffusion into the venous circulation/lack of strong adjuvants, difficulty in vaccine formulation | HIV-1 gp41, | 31 |
| Intravaginal/Rectal | Genital tract | Cream | High relevance for sexually transmitted diseases/difficulty in inoculation | HIV-1, HSV-2 | 32, 33 |
| Ocular | Ocular system | Drops | Generation of ocular mucosal immunity | HSV-2 | 34, 35 |
Abbreviation: HSV, Herpes simplex virus.